Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasoactive intestinal polypeptide in obesity.

G H Tomkin, J Ardill, H Lafferty

    International Journal of Obesity
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Commentary on High-density Lipoprotein Versus Low-density Lipoprotein Therapy and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes by Nikolaos Papageorgiou et al.

    Current cardiology reviews·2018
    Same author

    Diabetes and dyslipidemia: characterizing lipoprotein metabolism.

    Diabetes, metabolic syndrome and obesity : targets and therapy·2017
    Same author

    Restoration of fertility in prolactin induced premature menopause : A report of an eight year case study.

    Irish journal of medical science·2016
    Same author

    Comparison of the effect of parenteral with oral biguanide therapy on vitamin B12 and bile acid absorption.

    Irish journal of medical science·2016
    Same author

    Pituitary thyroid function and prolactin release following intravenous administration of TRH and pyroglutamyl-histidyl-prolyl-β alanine amide to healthy volunteers.

    Irish journal of medical science·2016
    Same author

    Gastrin levels after proximal gastric vagotomy.

    Irish journal of medical science·2016
    Same journal

    Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity.

    International journal of obesity·1991
    Same journal

    Sonography detection of small intra-abdominal fat variations.

    International journal of obesity·1991
    Same journal

    Obesity surgery: expectation and reality.

    International journal of obesity·1991
    Same journal

    Relationships between the amount of weight loss and post-heparin lipoprotein lipase activity in patients with type II diabetes.

    International journal of obesity·1991
    Same journal

    The individual and combined effects of cigarette smoking and food on resting energy expenditure.

    International journal of obesity·1991
    Same journal

    Oxygen consumption of muscles from ob/ob and Ay/a strains of obese mice.

    International journal of obesity·1991
    See all related articles

    Obese patients with high vasoactive intestinal polypeptide (VIP) levels struggle with weight loss. Lower triglyceride, gastric inhibitory polypeptide (GIP), and prolactin levels were observed in those who successfully lost weight.

    Area of Science:

    • Endocrinology
    • Metabolic Research
    • Obesity Studies

    Background:

    • Obesity is a complex metabolic condition often associated with hormonal imbalances.
    • Identifying biomarkers predictive of weight loss success is crucial for effective obesity management.

    Purpose of the Study:

    • To investigate the relationship between pre-treatment hormonal levels and weight loss outcomes in obese patients.
    • To explore the role of vasoactive intestinal polypeptide (VIP) in predicting weight loss success.

    Main Methods:

    • Twenty-six obese patients (>35% ideal weight) were assessed before a weight reduction program.
    • Hormone levels including VIP, GIP, prolactin, and triglyceride levels were measured.
    • Weight loss was evaluated after a three-month intervention period.

    Related Experiment Videos

    Main Results:

    • Seven patients lost >10% body weight; they exhibited lower triglyceride, fasting GIP, and prolactin levels.
    • Elevated fasting VIP levels were found in 19 patients who did not lose weight (P < 0.05).
    • High VIP levels correlated with higher triglycerides, C-terminal glucagon-like immunoreactivity (C-GLI), and post-glucose secretin levels.

    Conclusions:

    • Abnormally high VIP levels may be linked to obesity and impaired weight loss.
    • VIP and triglyceride levels show a significant correlation, suggesting a potential metabolic pathway involved in obesity.
    • Further research is warranted to understand the implications of VIP in weight management strategies.